Literature DB >> 34894417

Rate of continued conservative management versus progression to surgery at minimum 1-year follow-up in patients with pre-arthritic hip pain.

Abby L Cheng1,2, Reid W Collis3, Andrea B McCullough4, Mary Bui5, Brian K Brady4, Matthew J Schuelke6, John C Clohisy7, Graham A Colditz2, Heidi Prather8.   

Abstract

BACKGROUND: Extensive literature has described surgical outcomes for pre-arthritic hip pain, but the proportion of patients who progress to surgery remains unknown.
OBJECTIVE: To determine the proportion of patients who present to a tertiary referral center for pre-arthritic hip pain and progress to surgery at minimum 1-year follow-up.
DESIGN: Retrospective cohort study.
SETTING: Single tertiary care academic medical center. PATIENTS: Patients ages 13 to 40 years who presented for initial evaluation to a conservative or surgical orthopedic specialist and were diagnosed with pre-arthritic hip pain (n = 713 patients, 830 hips). INTERVENTION: Not applicable. MAIN OUTCOME MEASURES: The primary outcome was the rate of progression to surgery at minimum 1-year follow-up for the entire cohort. Predictors of progression to surgery were determined for the entire cohort and for radiographically defined subgroups using multiple logistic regression. Candidate predictors included baseline demographic, radiographic, clinical diagnosis, and patient-reported outcome measures.
RESULTS: In a cohort with a mean age of 25.4 (SD 8.1) years, 72.7% female, and mean follow-up of 2.6 (range 1.0-4.8) years, 429 of 830 hips (51.7%, 95% confidence interval [CI] 48.2% to 55.1%) progressed to surgery. Predictors of surgical progression in the entire cohort included younger age (OR 0.95/year, 95% CI 0.93 to 0.98), pain duration longer than 6 months (ORs 1.87-2.03, p ≤ .027), worse physical function (OR 0.96/Patient-Reported Outcomes Measurement Information System [PROMIS] point, 0.92 to 0.99), and a clinical diagnosis of femoroacetabular impingement (FAI) (OR 3.47, 2.05 to 5.89), acetabular dysplasia (OR 2.75, 1.73 to 4.35), and/or labral tear (OR 10.71, 6.98 to 16.47). Radiographic dysplasia (lateral center edge angle <20 degrees) increased the likelihood of surgery in all subgroups (ORs 2.05-8.47, p ≤ .008). Increasing maximum α angle increased the likelihood of surgery in patients with severe cam FAI (α > 63 degrees) (OR 1.03/degree, 1.00 to 1.06).
CONCLUSION: Almost half of patients with pre-arthritic hip pain did not progress to surgery at a minimum 1-year follow-up. A trial of conservative management is likely worthwhile in most patients.
© 2021 American Academy of Physical Medicine and Rehabilitation.

Entities:  

Mesh:

Year:  2022        PMID: 34894417      PMCID: PMC9149117          DOI: 10.1002/pmrj.12746

Source DB:  PubMed          Journal:  PM R        ISSN: 1934-1482            Impact factor:   2.218


  54 in total

1.  Cam and pincer femoroacetabular impingement: characteristic MR arthrographic findings in 50 patients.

Authors:  Christian W A Pfirrmann; Bernard Mengiardi; Claudio Dora; Fabian Kalberer; Marco Zanetti; Juerg Hodler
Journal:  Radiology       Date:  2006-07-20       Impact factor: 11.105

2.  Development of a PROMIS item bank to measure pain interference.

Authors:  Dagmar Amtmann; Karon F Cook; Mark P Jensen; Wen-Hung Chen; Seung Choi; Dennis Revicki; David Cella; Nan Rothrock; Francis Keefe; Leigh Callahan; Jin-Shei Lai
Journal:  Pain       Date:  2010-07       Impact factor: 6.961

3.  Factors Associated with Initial Interest and Treatment Selection in Patients with Femoroacetabular Impingement Syndrome.

Authors:  Kathryn Glaws; Lindsey Brown-Taylor; Matthew Pomeroy; Stephanie Di Stasi; Julie M Fritz; John Ryan; Bryant Walrod; William K Vasileff
Journal:  PM R       Date:  2020-03-12       Impact factor: 2.298

4.  The Warwick Agreement on femoroacetabular impingement syndrome (FAI syndrome): an international consensus statement.

Authors:  D R Griffin; E J Dickenson; J O'Donnell; R Agricola; T Awan; M Beck; J C Clohisy; H P Dijkstra; E Falvey; M Gimpel; R S Hinman; P Hölmich; A Kassarjian; H D Martin; R Martin; R C Mather; M J Philippon; M P Reiman; A Takla; K Thorborg; S Walker; A Weir; K L Bennell
Journal:  Br J Sports Med       Date:  2016-10       Impact factor: 13.800

Review 5.  Measures of hip function and symptoms: Harris Hip Score (HHS), Hip Disability and Osteoarthritis Outcome Score (HOOS), Oxford Hip Score (OHS), Lequesne Index of Severity for Osteoarthritis of the Hip (LISOH), and American Academy of Orthopedic Surgeons (AAOS) Hip and Knee Questionnaire.

Authors:  Anna Nilsdotter; Ann Bremander
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

6.  Advances in Patient-Reported Outcomes: The NIH PROMIS(®) Measures.

Authors:  Joan E Broderick; Esi Morgan DeWitt; Nan Rothrock; Paul K Crane; Christopher B Forrest
Journal:  EGEMS (Wash DC)       Date:  2013-08-02

7.  Conservative management acutely improves functional movement and clinical outcomes in patients with pre-arthritic hip pain.

Authors:  Ryan P McGovern; RobRoy L Martin; Amy L Phelps; Benjamin R Kivlan; Beth Nickel; John J Christoforetti
Journal:  J Hip Preserv Surg       Date:  2020-01-22

8.  Rate of Surgery and Baseline Characteristics Associated With Surgery Progression in Young Athletes With Prearthritic Hip Disorders.

Authors:  Reid W Collis; Andrea B McCullough; Chris Ng; Heidi Prather; Graham A Colditz; John C Clohisy; Abby L Cheng
Journal:  Orthop J Sports Med       Date:  2020-11-24

Review 9.  A Systematic Assessment of YouTube Content on Femoroacetabular Impingement: An Updated Review.

Authors:  Connor R Crutchfield; Jessie S Frank; Matthew J Anderson; David P Trofa; T Sean Lynch
Journal:  Orthop J Sports Med       Date:  2021-06-29

10.  Hip arthroscopy versus best conservative care for the treatment of femoroacetabular impingement syndrome (UK FASHIoN): a multicentre randomised controlled trial.

Authors:  Damian R Griffin; Edward J Dickenson; Peter D H Wall; Felix Achana; Jenny L Donovan; James Griffin; Rachel Hobson; Charles E Hutchinson; Marcus Jepson; Nick R Parsons; Stavros Petrou; Alba Realpe; Joanna Smith; Nadine E Foster
Journal:  Lancet       Date:  2018-06-01       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.